Advertisement

BioMetals

, Volume 32, Issue 2, pp 307–315 | Cite as

Assessment of cell-free levels of iron and copper in patients with Friedreich’s ataxia

  • Deepti Pathak
  • Achal Kumar Srivastava
  • Sheffali Gulati
  • Moganty R. RajeswariEmail author
Article
  • 75 Downloads

Abstract

Friedreich’s ataxia (FRDA), a progressive neurodegenerative disorder caused by trinucleotide (GAA) repeat expansion in frataxin (fxn) gene which results in decreased levels of frataxin protein. Insufficient frataxin levels leads to iron and copper deposits in the brain and cardiac cells. A total of hundred and twenty patients, suspected of FRDA were screened for the (GAA) repeats in the fxn gene and only confirmed patients (n = 25) were recruited in the study. The total Iron and total copper concentrations were measured in blood plasma using Nitro PAPS and Dibrom PAESA method, respectively both in patients and age, sex matched healthy controls. The iron levels mean ± SD (6.2 ± 3.8) in plasma of FRDA patients were found to be significantly decreased as compared to healthy controls mean ± SD (15.2 ± 4.2). A similar trend was observed in case of plasma copper levels in FRDA patient (8.15 ± 4.6) as compared to controls (17.5 ± 3.40). Present results clearly prove abnormal distribution of extra-cellular iron in FRDA patients, which is in accordance with the well established fact of intracellular iron overload, which is the key feature of the pathogenesis of this disease. This can be of importance in understanding the pathophysiology of the disease in association with frataxin/iron. It appears that intracellular sequestration of trace metals in FRDA patients (due to low frataxin) results in their sub-optimal levels in blood plasma (extra-cellular) an observation that can find prognostic application in clinical trials.

Keywords

Friedreich’s ataxia (FRDA) Neurodegenerative disorder Mitochondrial iron accumulation Plasma iron and copper ROS 

Notes

Acknowledgements

We thank all the FRDA patients and healthy volunteers for their participation. The authors would like to thank Dr. Ashok Sharma (Dept of Biochemistry, AIIMS) for kind permission to use the Bioanalyzer for trace metal analysis. The financial support from the intra-mural grant from All India Institute of Medical Sciences (AIIMS) New Delhi (A-497) is gratefully acknowledged.

Author contribution

MRR: Conceived the idea, designed the experiments and wrote the manuscript. AKS and SG: Provided the FRDA patient samples. DP: Executed the experiments, acquired the raw data and wrote the first draft of the manuscript. All authors were involved in interpreting the data. All authors approved the final manuscript.

Funding

The financial support from the intra-mural grant from AIIMS, New Delhi (A-497) is gratefully acknowledged. DP received Research Fellowship from Indian council of Medical Research, No 3/1/3/JRF-2012).

Compliance with ethical standards

Conflict of interest

The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

References

  1. Abeti R, Parkinson MH, Hargreaves IP, Angelova PR, Sandi C, Pook MA, Giunti P, Abramov AY (2016) Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich’s ataxia. Cell Death Dis.  https://doi.org/10.1038/cddis.2016.111 PubMedCentralGoogle Scholar
  2. Adinolfi S, Iannuzzi C, Prischi F, Pastore C, Iametti S, Martin SR, Bonomi F, Pastore A (2009) Bacterial Frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nat Struct Mol Biol.  https://doi.org/10.1038/nsmb.1579 Google Scholar
  3. Ayton S, Lei P, Duce JA, Wong BXW, Sedjahtera A, Adlard PA, Bush AI, Finkelstein DI (2013) Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol.  https://doi.org/10.1002/ana.23817 Google Scholar
  4. Babcock M, De Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, Kaplan J (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science.  https://doi.org/10.1126/science.276.5319.1709 Google Scholar
  5. Becker EM, Greer JM, Ponka P, Richardson DR (2002) Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization. Blood.  https://doi.org/10.1182/blood.V99.10.3813 Google Scholar
  6. Bürk K (2017) Friedreich ataxia: current status and future prospects. Cerebellum Ataxias.  https://doi.org/10.1186/s40673-017-0062-x PubMedCentralGoogle Scholar
  7. Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E et al (1996) Friedreich’s Ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science.  https://doi.org/10.1126/science.271.5254.1423 Google Scholar
  8. Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, Trottier Y et al (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet.  https://doi.org/10.1093/hmg/6.11.1771 Google Scholar
  9. Colin F, Martelli A, Clémancey M, Latour JM, Gambarelli S, Zeppieri L, Birck C, Page A, Puccio H, De Choudens SO (2013) Mammalian Frataxin controls sulfur production and iron entry during de Novo Fe4S4 cluster assembly. J Am Chem Soc.  https://doi.org/10.1021/ja308736e Google Scholar
  10. Cossee M, Schmitt M, Campuzano V, Reutenauer L, Moutou C, Mandel JL, Koenig M (1997) Evolution of the Friedreich’s ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci USA.  https://doi.org/10.1073/pnas.94.14.7452 Google Scholar
  11. Cossée M, Dürr A, Schmitt M, Dahl N, Trouillas P, Allinson P, Kostrzewa M et al (1999) Friedreich’s ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol 45(2):200–206CrossRefGoogle Scholar
  12. Crooks DR, Natarajan TG, Jeong SY, Chen C, Park SY, Huang H, Ghosh MC et al (2014) Elevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle. Hum Mol Genet.  https://doi.org/10.1093/hmg/ddt393 Google Scholar
  13. Dantham S, Srivastava AK, Gulati S, Rajeswari MR (2016) Plasma circulating cell-free mitochondrial DNA in the assessment of Friedreich’s ataxia. J Neurol Sci.  https://doi.org/10.1016/j.jns.2016.04.016 Google Scholar
  14. Dantham S, Ak S, Gulati S, Rajeswari MR (2018) Differentially regulated cell-free MICRORNAS in the plasma of Friedreich’s Ataxia patients and their association with disease pathology. Neuropediatrics.  https://doi.org/10.1055/s-0037-1607279 Google Scholar
  15. Delatycki MB, Tai ZG, Corben L, Yiu EM, Evans-Galea MV, Stephenson SEM, Gurrin L, Allen KJ, Lynch D, Lockhart PJ (2014) HFE pC282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia. Mov Disord.  https://doi.org/10.1002/mds.25795 Google Scholar
  16. Ebadi M, Sharma S (2006) Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in parkinson disease. Exp Biol Med.  https://doi.org/10.1177/153537020623100919 Google Scholar
  17. Foury F, Roganti T (2002) Deletion of the mitochondrial carrier genes MRS3 and MRS4 suppresses mitochondrial iron accumulation in a yeast frataxin-deficient strain. J Biol Chem.  https://doi.org/10.1074/jbc.M111789200 Google Scholar
  18. Foury F, Pastore A, Trincal M (2007) Acidic residues of yeast frataxin have an essential role in Fe-S cluster assembly. EMBO Rep.  https://doi.org/10.1038/sj.embor.7400881 Google Scholar
  19. Harding AE (1981) Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain.  https://doi.org/10.1093/brain/104.3.589 Google Scholar
  20. Heidari MM, Houshmand M, Hosseinkhani S, Nafissi S, Khatami M (2009) Complex I and ATP content deficiency in lymphocytes from Friedreich’s ataxia. Can J Neurol Sci.  https://doi.org/10.1017/S0317167100006260 Google Scholar
  21. Huang MLH, Becker EM, Whitnall M, Rahmanto YS, Ponka P, Richardson DR (2009) Elucidation of the mechanism of mitochondrial iron loading in Friedreich’s ataxia by analysis of a mouse mutant. Proc Natl Acad Sci USA 1:4.  https://doi.org/10.1073/pnas.0906784106 Google Scholar
  22. Jasoliya MJ, Mcmackin MZ, Henderson CK, Perlman SL, Cortopassi GA (2017) Frataxin deficiency impairs mitochondrial biogenesis in cells, mice and humans. Hum Mol Genet 26(14):2627–2633.  https://doi.org/10.1093/hmg/ddx141 CrossRefPubMedCentralGoogle Scholar
  23. Jauslin ML, Wirth T, Meier T, Schoumacher F (2002) A cellular model for Friedreich ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet 11(24):3055–3063CrossRefGoogle Scholar
  24. Karthikeyan G, Santos JH, Graziewicz MA, Copeland WC, Isaya G, Van Houten B, Resnick MA (2003) Reduction in frataxin causes progressive accumulation of mitochondrial damage. Hum Mol Genet 12:3331–3342.  https://doi.org/10.1093/hmg/ddg349 CrossRefGoogle Scholar
  25. Knight SAB, Sepuri NBV, Pain D, Dancis A (1998) Mt-Hsp70 homolog, Ssc2p, required for maturation of yeast frataxin and mitochondrial iron homeostasis. J Biol Chem 273(29):18389–18393.  https://doi.org/10.1074/jbc.273.29.18389 CrossRefGoogle Scholar
  26. Koeppen AH, Michael SC, Knutson MD, Haile DJ, Qian J, Levi S, Santambrogio P, Garrick MD, Lamarche JB (2007) The dentate nucleus in Friedreich’s ataxia: the role of iron-responsive proteins. Acta Neuropathol 114:163–173.  https://doi.org/10.1007/s00401-007-0220-y CrossRefGoogle Scholar
  27. Koeppen AH, Kuntzsch EC, Bjork ST, Ramirez RL, Mazurkiewicz JE, Feustel PJ (2013) Friedreich ataxia: metal dysmetabolism in dorsal root ganglia. Acta Neuropathol Commun 1:26.  https://doi.org/10.1186/2051-5960-1-26 CrossRefPubMedCentralGoogle Scholar
  28. Kruger PC, Yang KX, Parsons PJ, Becker AB, Feustel PJ, Koeppen AH (2016) Abundance and significance of iron, zinc, copper, and calcium in the hearts of patients with Friedreich ataxia. Am J Cardiol.  https://doi.org/10.1016/j.amjcard.2016.04.024 PubMedCentralGoogle Scholar
  29. Kuhn V, Diederich L, Keller TCS, Kramer CM, Lückstädt W, Panknin C, Suvorava T, Isakson BE, Kelm M, Cortese-Krott MM (2017) Red blood cell function and dysfunction: redox regulation, nitric oxide metabolism, anemia. Antioxid Redox Signal.  https://doi.org/10.1089/ars.2016.6954 PubMedCentralGoogle Scholar
  30. Lodi R, Cooper JM, Bradley JL, Manners D, Styles P, Taylor DJ, Schapira AHV (1999) Deficit of in vivo mitochondrial atp production in patients with Friedreich ataxia. Proc Natl Acad Sci USA 4:1.  https://doi.org/10.1073/pnas.96.20.11492 Google Scholar
  31. Lupoli F, Vannocci T, Longo G, Niccolai N, Pastore A (2018) The role of oxidative stress in Friedreich’s ataxia. FEBS Lett 592:718–727.  https://doi.org/10.1002/1873-3468.12928 CrossRefGoogle Scholar
  32. Moganty R (2014) DNA triplex structures in neurodegenerative disorder, Friedreich’s ataxia. J Biosci.  https://doi.org/10.1007/s12038-012-9219-1 Google Scholar
  33. Mühlenhoff U, Richhardt N, Ristow M, Kispal G, Lill R, Mu U (2002) The yeast Frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Hum Mol Genet 11:2025–2036.  https://doi.org/10.1093/hmg/11.17.2025 CrossRefGoogle Scholar
  34. Napoli E, Taroni F, Cortopassi GA (2006) Frataxin, iron–sulfur clusters, heme, ROS, and aging. Antioxid Redox Signal.  https://doi.org/10.1089/ars.2006.8.506 PubMedCentralGoogle Scholar
  35. Pandolfo M, Pastore A (2009) The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J Neurol.  https://doi.org/10.1007/s00415-009-1003-2 Google Scholar
  36. Prischi F, Konarev PV, Iannuzzi C, Pastore C, Adinolfi S, Martin SR, Svergun DI, Pastore A (2010) Structural bases for the interaction of Frataxin with the central components of iron-sulphur cluster assembly. Nat Commun.  https://doi.org/10.1038/ncomms1097 PubMedCentralGoogle Scholar
  37. Puccio H, Simon D, Cossée M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, Koenig M (2001) Mouse models for friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet.  https://doi.org/10.1038/84818 Google Scholar
  38. Ramirez RL, Qian J, Santambrogio P, Levi S, Koeppen AH (2012) Relation of cytosolic iron excess to cardiomyopathy of Friedreich’s ataxia. Am J Cardiol.  https://doi.org/10.1016/j.amjcard.2012.08.018 PubMedCentralGoogle Scholar
  39. Richardson DR, Lane DJR, Becker EM, Huang MLH, Whitnall M, Rahmanto YS, Sheftel AD, Ponka P (2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci USA.  https://doi.org/10.1073/pnas.0912925107 Google Scholar
  40. Rotig A, de Lonlay PD, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P (1997) Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet.  https://doi.org/10.1038/ng1097-215 Google Scholar
  41. Shidara Y, Hollenbeck PJ (2010) Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a drosophila model of Friedreich ataxia. J Neurosci 2:4.  https://doi.org/10.1523/JNEUROSCI.0529-10.2010 Google Scholar
  42. Singh I, Faruq M, Padma MV, Behari M, Grover A, Mukerji M, Srivastava AK (2015) MITOCH. Elsevier B.V, Amsterdam.  https://doi.org/10.1016/j.mito.2015.08.003 Google Scholar
  43. Singh I, Shakya S, Singh RK, Ahmad I, Goyal V, Shukla G, Srivastava MV, Faruq M, Srivastava AK (2017) Iron related hemochromatosis (HFE) gene mutations in Friedreich ataxia patients. Parkinsonism Relat Disord 34:71–72.  https://doi.org/10.1016/j.parkreldis.2016.10.015 CrossRefGoogle Scholar
  44. Swarup V, Rajeswari MR (2007) Circulating (cell-free) nucleic acids—a promising, non-invasive tool for early detection of several human diseases. FEBS Lett 581:795–799.  https://doi.org/10.1016/j.febslet.2007.01.051 CrossRefGoogle Scholar
  45. Swarup V, Srivastava AK, Padma MV, Rajeswari MR (2013) Quantitative profiling and identification of differentially expressed plasma proteins in Friedreich’s ataxia. J Neurosci Res 1491:1483–1491.  https://doi.org/10.1002/jnr.23262 CrossRefGoogle Scholar
  46. Whitnall M, Rahmanto YS, Sutak R, Xu X, Becker EM, Mikhael MR, Ponka P, Richardson DR (2008) The MCK mouse heart model of Friedreich’s ataxia: alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation. Proc Nat Acad Sci USA.  https://doi.org/10.1073/pnas.0804261105 Google Scholar
  47. Whitnall M, Rahmanto YS, Huang MLH, Saletta F, Lok HC, Gutierrez L, Lazaro FJ et al (2012) Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich Ataxia. Proc Nat Acad Sci USA.  https://doi.org/10.1073/pnas.1215349109 Google Scholar
  48. Willis JH, Isaya G, Gakh O, Capaldi RA, Marusich MF (2008) Lateral-flow immunoassay for the frataxin protein in Friedreich’s ataxia patients and carriers. Mol Genet Metab 94:491–497.  https://doi.org/10.1016/j.ymgme.2008.03.019 CrossRefPubMedCentralGoogle Scholar
  49. Wilson RB, Lynch DR, Farmer JM, Brooks DG, Fischbeck KH (2000) Increased serum transferrin receptor concentrations in Friedreich ataxia. Ann Neurol 47:659–661CrossRefGoogle Scholar
  50. Wingert RA, Galloway JL, Barut B, Foott H, Fraenkel P, Axe JL, Weber GJ et al (2005) Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature.  https://doi.org/10.1038/nature03887 Google Scholar
  51. Ye H, Rouault TA (2010) Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry.  https://doi.org/10.1021/bi1004798 Google Scholar
  52. Zhao HW, Lin J, Wang XB, Cheng X, Wang JY, Hu BL, Zhang Y (2013) Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson’s disease. PLoS ONE 8(12):1–10.  https://doi.org/10.1371/journal.pone.0083060 Google Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of BiochemistryAll India Institute of Medical SciencesNew DelhiIndia
  2. 2.Department of NeurologyAll India Institute of Medical SciencesNew DelhiIndia
  3. 3.Department of PaediatricsAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations